Skip to main content
Premium Trial:

Request an Annual Quote

Barcode Consortium Nets Over $6M from Ontario, New South Wales Funding

NEW YORK (GenomeWeb News) – The International Barcode of Life (iBOL) consortium, a Canadian-led venture aimed at developing a database that would help identify a species based on its DNA sequence, has gained roughly CDN$5.15 million (US$5.16M) in funding from the Ontario Ministry of Research and Innovation.
The consortium also recently received an approximately AUS$1.2 million (US$1.1M) pledge from the New South Wales Department of Primary Industries.
The iBOL consortium intends to raise CDN$150 million to develop a reference data set of five million DNA sequences, including 10 specimens per species, which will serve as a "global resource" that could help in “monitoring food purity, invasive or endangered species, industrial fouling, and environmental impact."
Along with the investment from the NSW’s DPI, the Australian Museum and the Botanic Gardens Trust in Sydney will work to help create an Australian node for the iBOL program.
The barcoding research iBOL is using also was funded in part by Genome Canada, Canada’s Natural Sciences and Engineering Research Council, the Canadian Foundation for Innovation, the Sloan Foundation, and the Moore Foundation, said OGI President and CEO Christian Burks.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.